IRIS
MATUCCI CERINIC, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.878
EU - Europa 10.429
NA - Nord America 8.755
SA - Sud America 2.117
AF - Africa 184
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 1
Totale 33.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.389
RU - Federazione Russa 6.304
SG - Singapore 5.256
CN - Cina 3.306
BR - Brasile 1.784
HK - Hong Kong 1.575
IT - Italia 1.373
VN - Vietnam 856
FR - Francia 708
RO - Romania 708
DE - Germania 333
GB - Regno Unito 225
BD - Bangladesh 216
CA - Canada 185
NL - Olanda 171
IN - India 158
SE - Svezia 127
MX - Messico 121
AR - Argentina 119
FI - Finlandia 89
AT - Austria 88
PL - Polonia 80
TR - Turchia 80
EC - Ecuador 59
JP - Giappone 59
IQ - Iraq 56
ES - Italia 52
ZA - Sudafrica 52
ID - Indonesia 40
CO - Colombia 35
MA - Marocco 35
UZ - Uzbekistan 35
UA - Ucraina 33
VE - Venezuela 33
PK - Pakistan 26
LT - Lituania 25
PY - Paraguay 24
CL - Cile 23
SA - Arabia Saudita 23
TN - Tunisia 22
EG - Egitto 19
MY - Malesia 19
PH - Filippine 19
CH - Svizzera 18
IL - Israele 16
PE - Perù 16
UY - Uruguay 16
AU - Australia 15
JO - Giordania 15
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
JM - Giamaica 13
TW - Taiwan 13
NP - Nepal 12
PT - Portogallo 12
SN - Senegal 12
KE - Kenya 11
TH - Thailandia 11
DO - Repubblica Dominicana 9
AZ - Azerbaigian 8
BE - Belgio 8
MD - Moldavia 8
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
CZ - Repubblica Ceca 7
GR - Grecia 7
KR - Corea 7
KZ - Kazakistan 7
LV - Lettonia 7
OM - Oman 7
CR - Costa Rica 6
CY - Cipro 6
ET - Etiopia 6
HU - Ungheria 6
IR - Iran 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
LU - Lussemburgo 5
PA - Panama 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
GT - Guatemala 4
QA - Qatar 4
AM - Armenia 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
GY - Guiana 3
HN - Honduras 3
IE - Irlanda 3
KG - Kirghizistan 3
BB - Barbados 2
BN - Brunei Darussalam 2
BW - Botswana 2
HR - Croazia 2
LB - Libano 2
MK - Macedonia 2
Totale 33.357
Salva come PNG Salva come JPEG
Città #
Dallas 2.933
Singapore 2.553
San Jose 1.661
Hong Kong 1.563
Moscow 1.440
Ashburn 1.165
Hefei 629
Shanghai 614
Lauterbourg 547
Beijing 346
Ho Chi Minh City 313
New York 230
Hanoi 189
Milan 185
Los Angeles 175
São Paulo 155
Rome 134
Santa Clara 118
Nuremberg 109
Munich 74
Rio de Janeiro 74
Orem 68
Council Bluffs 67
Warsaw 64
Montreal 63
Brooklyn 61
Boardman 58
Guangzhou 58
Atlanta 57
Amsterdam 53
Chicago 53
Mexico City 53
Florence 50
Stockholm 50
Tokyo 50
Denver 48
Chennai 47
London 43
Da Nang 42
Phoenix 40
San Francisco 40
Boston 38
Bologna 37
Brasília 36
Frankfurt am Main 36
Toronto 36
Buffalo 34
Johannesburg 34
Vienna 33
Assago 32
Belo Horizonte 32
Lappeenranta 32
Naples 32
Helsinki 31
Hangzhou 29
Shenzhen 29
Tashkent 29
Haiphong 26
Houston 26
Tianjin 26
Turin 26
Palermo 25
Guayaquil 24
Turku 24
Washington 24
Manchester 23
North Bergen 23
The Dalles 23
Porto Alegre 22
Baghdad 21
Poplar 21
Dhaka 20
Istanbul 20
Seattle 20
St Louis 20
Clifton 19
Curitiba 19
Hải Dương 19
Paris 19
Ankara 18
Charlotte 18
Mumbai 18
Salvador 18
Secaucus 18
Lawrence 17
Princeton 17
Santo André 17
Bari 16
Campinas 16
Goiânia 16
New Delhi 16
Quito 16
Biên Hòa 15
Cagliari 15
Can Tho 15
Guarulhos 15
Philadelphia 15
Casablanca 14
Phủ Lý 14
Ribeirão Preto 14
Totale 17.630
Salva come PNG Salva come JPEG
Nome #
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 569
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 455
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 429
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: A EUSTAR database analysis 402
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database 395
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 384
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 345
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 333
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 238
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 230
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 153
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliability 147
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 142
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 131
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 126
"Autoimmunity" - Chapter: Autoantibodies in systemic sclerosis 124
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 118
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 117
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 112
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative 110
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 110
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 109
A custom-made splint is useful in the treatment of Osteoarthritis of the trapeziometacarpal joint 107
Very early and early diagnosis of systemic sclerosis 106
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 106
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 106
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation 105
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 103
Managing complicated digital ulcers 102
A contribution to the debate about the possible different clinical severity between hemophilia A and B 102
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs] 102
A comparison of two podiatric protocols for metatarsalgia in patients with rheumatoid arthritis and osteoarthritis 101
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 100
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 100
The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients 100
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 99
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 98
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 97
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 97
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 97
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity 96
"Epigenetic in rheumatic diseases" - Chapter: Epigenetics in systemic sclerosis 96
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative 96
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 95
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 95
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 94
Historical perspective of scleroderma 93
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis] 92
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases 91
A combined rehabilitative program is efficacious in the treatment of hands of Systemic Sclerosis patients 91
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis 91
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 91
Editorial: Cardiovascular involvement in autoimmune diseases, volume II 91
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 90
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 90
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 90
A genetic variant located in the promoter of the uPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 89
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 88
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 87
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 85
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 84
Riabilitazione dell’articolazione temporomandibolare (atm) in pazienti con sclerosi sistemica (ssc): confronto tra due protocolli. Risultati preliminari 84
Infection-Associated Flares in Systemic Lupus Erythematosus 84
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 84
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 84
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 84
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 84
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 83
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 83
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 81
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 80
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 79
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 78
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study 77
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 77
The combination of connective tissue massage, Kabat's technique, kinesitherapy and home exercise is helpful in face rehabilitation of Systemic Sclerosis patients 77
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 77
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis 76
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review 75
A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review 74
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 74
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 74
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 73
LA PROSPETTIVA DEI PAZIENTI REUMATICI SULL’UTILITÀ DELLA TELEMEDICINA PER IL FOLLOW UP DELLA MALATTIA: ESPERIENZE E PROBLEMATICHE ORGANIZZATIVE DURANTE LA PANDEMIA 73
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 73
Hand Function in Scleroderma 72
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 72
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 72
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 71
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report 70
Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters 70
Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy) 70
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 70
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort 69
Stressful life events at the onset and during the evolution of systemic sclerosis 69
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 68
Raynaud's phenomenon, digital ulcers and nailfold capillaroscopy 68
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 67
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 66
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 66
Totale 11.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 11 3 1 3 1 0 0 16 1 2
2022/2023170 42 28 9 1 3 16 29 20 15 0 6 1
2023/20241.249 4 9 14 20 18 574 222 176 10 26 48 128
2024/20258.238 986 202 92 159 357 567 1.513 542 1.358 1.183 612 667
2025/202624.733 1.984 2.651 2.404 2.679 1.577 670 3.092 1.584 5.682 1.366 998 46
Totale 34.433